Literature DB >> 2998905

Involvement of cyclic AMP, iodide and metabolites of arachidonic acid in the regulation of cell proliferation of isolated porcine thyroid follicles.

R Gärtner, W Greil, R Demharter, K Horn.   

Abstract

Experiments with primary cultures of isolated porcine thyroid follicles were performed in serum-free well-defined medium to investigate different pathways that may be involved in the regulation of thyroid cell growth. The incorporation of [3H]thymidine into DNA within 72 h was about 25-fold with fetal calf serum (FCS, 1%), 20-fold with epidermal growth factor (EGF, 1 ng/ml) and 3.5-fold with insulin (10 micrograms/ml) as compared to controls. Bovine TSH significantly reduced the basal and insulin-induced growth rate at concentrations of 10(-6) to 10(-4) U/ml and 10(-4) U/ml, respectively. Forskolin stimulated cyclic AMP accumulation in thyroid cells and significantly reduced FCS-, EGF- or insulin-induced growth. In contrast, a 2- to 7-fold increase in FCS-, insulin- or EGF-induced growth rate was found, when cyclic AMP formation was inhibited by 2',5'-dideoxyadenosine (DDA). Iodide was stimulatory at low concentrations (1 microM) and inhibitory at higher concentrations (40-80 microM) on FCS-induced growth rate. The inhibitory effect of iodide was blocked by propylthiouracil (PTU), indicating that an iodinated compound is responsible for this effect. Indomethacin, a cyclooxygenase inhibitor, did not inhibit EGF- and insulin-induced growth up to a concentration of 100 microM. However, nordihydroguaiaretic acid (NDGA) and BW-755C, which are lipoxygenase inhibitors, strongly inhibited the growth of thyroid cells at micromolar concentrations. These data clearly show that (1) bovine TSH is not a growth factor for isolated thyroid cells in vitro, (2) thyroid cell proliferation, induced by FCS, EGF and insulin is under negative control of cyclic AMP. (3) Iodide controls dose-dependently thyroid cell growth by iodinated metabolites, probably modulating 2 different pathways: (a) at low iodide concentrations, an iodinated compound enhances the growth rate by inhibition of cyclic AMP formation, and (b) at high concentrations, iodide diminishes the growth rate by inhibiting the response to growth factors. (4) Metabolite(s) of lipoxygenase appear to be involved in intracellular signal transduction evoked by growth factors in thyroid cells.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2998905     DOI: 10.1016/0303-7207(85)90102-9

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  11 in total

1.  [Treatment of euthyroid struma. Comparable volume reduction with 400 micrograms iodine, 100 micrograms levothyroxine combined with 100 micrograms iodine or individually dosed levothyroxine].

Authors:  H Peters; D Hackel; H Schleusener
Journal:  Med Klin (Munich)       Date:  1997-02-15

2.  Demonstration of the production and physiological role of insulin-like growth factor II in rat thyroid follicular cells in culture.

Authors:  R M Maciel; A C Moses; G Villone; D Tramontano; S H Ingbar
Journal:  J Clin Invest       Date:  1988-11       Impact factor: 14.808

3.  Screening the ToxCast Phase 1, Phase 2, and e1k Chemical Libraries for Inhibitors of Iodothyronine Deiodinases.

Authors:  Jennifer H Olker; Joseph J Korte; Jeffrey S Denny; Phillip C Hartig; Mary C Cardon; Carsten N Knutsen; Paige M Kent; Jessica P Christensen; Sigmund J Degitz; Michael W Hornung
Journal:  Toxicol Sci       Date:  2019-04-01       Impact factor: 4.849

4.  The tissue-specific pathways regulating cell proliferation are inherited independently in somatic hybrid between thyroid and liver cells.

Authors:  B M Veneziani; G Villone; R Romano; A Di Carlo; C Garbi; D Tramontano
Journal:  J Cell Biol       Date:  1990-12       Impact factor: 10.539

5.  [Bioequivalence of a combination of levothyroxine and iodine in comparison with levothyroxine only. A controlled double-blind study of bioavailability].

Authors:  G Förster; C Hansen; F Mörsch; K al-Hakim; J Beyer; G Kahaly
Journal:  Med Klin (Munich)       Date:  1998-07-15

6.  Iodine vs thyroxine. A changing concept of therapy in endemic goiter?

Authors:  G Hintze; J Köbberling
Journal:  Klin Wochenschr       Date:  1987-07-01

7.  Activation of 5-HT1A receptors expressed in NIH-3T3 cells induces focus formation and potentiates EGF effect on DNA synthesis.

Authors:  A Varrault; J Bockaert; C Waeber
Journal:  Mol Biol Cell       Date:  1992-09       Impact factor: 4.138

8.  Pendred syndrome in two Galician families: insights into clinical phenotypes through cellular, genetic, and molecular studies.

Authors:  Fernando Palos; María E R García-Rendueles; David Araujo-Vilar; Maria Jesús Obregon; Rosa Maria Calvo; Jose Cameselle-Teijeiro; Susana B Bravo; Oscar Perez-Guerra; Lourdes Loidi; Barbara Czarnocka; Paula Alvarez; Samuel Refetoff; Lourdes Dominguez-Gerpe; Clara V Alvarez; Joaquin Lado-Abeal
Journal:  J Clin Endocrinol Metab       Date:  2007-10-16       Impact factor: 5.958

9.  Effects of excess iodine in chick embryo thyroid follicles: initial inhibition and subsequent hypertrophy.

Authors:  Z Guo; R Narbaitz; J N Fryer
Journal:  J Anat       Date:  1991-06       Impact factor: 2.610

10.  Insulin and insulin-like growth factor (IGF I) modulate the effects of bTSH on 3H-thymidine incorporation in human thyroid cells in primary culture.

Authors:  R Hoermann; B Saller; K Mann
Journal:  Klin Wochenschr       Date:  1989-10-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.